igmbio.com (IGMS) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Experts value IGM Biosciences, Inc. (IGMS) for its cutting-edge IgM antibody therapy platform and successful pivot toward treating autoimmune pathologies. The company is automating laboratory bioprocesses by deploying robots for the screening of anti-cancer components. The price trend based on the EV/EBITDA metric is , which complements the business profile. The development of unique molecules provides the firm with a competitive advantage when partnering with global pharmaceutical behemoths.
igmbio.com - analytical breakdowns and key metrics (IGMS)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
IGMS - Net Income|Future Profit IGM Biosciences, Inc.|IGMS - Company Value to Net Income|Forward P/E Multiple IGM Biosciences|IGMS - Price/Earnings to Growth Ratio|EV/EBITDA Multiple IGM Biosciences, Inc.|IGMS - Operating income before deduction of amortization|Earnings per share for the last twelve months IGM Biosciences|IGMS - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months igmbio.com|IGMS - Expected net earnings per share growth this year|Earnings growth forecast for next year IGM Biosciences, Inc.
Initial company analysis:IGM Bio IGMS
The multiple correlates the total enterprise value with its operating profit before interest and taxes, determining the asset's real price. By analyzing the EV/EBITDA ratio of a capital-intensive business, an investor identifies stock overvaluation and assesses debt management efficiency. For IGM Biosciences, Inc. (IGMS), such a metric confirms the resilience of a model where patent protection for bispecific antibodies optimizes R&D costs.
Analysis of competing companies
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|Vera Pharma - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Dianthus Corp DNTH|PHVS: EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple AbCellera ABCL|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tourmaline Bio|Enterprise Value to EBITDA Ratio Precigen Inc (PGEN)|Enterprise Value to EBITDA Ratio PHAR (Pharming)|NKTR (Nektar Corp) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple UPB (Upstream Bio Inc)|zenasbio.com - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Immunome - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Gossamer Bio Inc GOSS|KalVista Pharmaceuticals Inc (KALV) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Septerna Pharma (SEPN)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pieris Pharmaceuticals|savarapharma.com (SVRA) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple RIGL|Enterprise Value to EBITDA Ratio AnaptysBio Inc ANAB|EV/EBITDA Multiple ATXS (Astria Pharma)|Total Company Value to Operating Income Before Depreciation Ratio enGene Corp (ENGN)|RAPT Therapeutics - EV/EBITDA Multiple|Company Value to EBITDA Aerovate Therapeutics Inc|Aclaris Therapeutics, Inc. (ACRS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation KYTX|TLSA (Tiziana Life Sciences PLC) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Cabaletta Bio Inc (CABA)|EV/EBITDA Multiple VTYX|THTX - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Avalo Therapeutics AVTX|Total Company Value to Operating Income Before Depreciation Ratio Eledon Pharmaceuticals Inc. (ELDN)|AGEN: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation CLYM (Climb Bio, Inc)|ZURA: EV/EBITDA Multiple|ATYR - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adagene Inc|Enterprise Value to Operating Income Before Depreciation IMA (Ikena Oncology, Inc.)|EV/EBITDA Multiple STTK|Enterprise Value to EBITDA Ratio equilliumbio.com EQ|Connect Biopharma Holdings Limited - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio Immunic Therapeutics (IMUX)|Atara Biotherapeutics Inc - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio InflaRx N.V. IFRX|XFOR: EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple Adicet Bio, Inc. ACET|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Celularity Inc|Enterprise Value to EBITDA Ratio inmunebio.com (INMB)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Barinthus Biotherapeutics plc (BRNS)|Total Company Value to Operating Income Before Depreciation Ratio Kezar Life Sciences Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SAB Biotherapeutics, Inc SABS|AKTX (Akari Therapeutics, Plc) - Company Value to Operating Income Before Depreciation Ratio|Enlivex Therapeutics, Ltd. - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation QTTB (Q32 Bio Inc.)|GOVX: EV/EBITDA Multiple|Edesa Biotech Inc (EDSA) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization iBio Corp|CARM: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization XTL Biopharmaceuticals (XTLB)|Enterprise Value to EBITDA Ratio boltbio.com BOLT|EV/EBITDA Multiple HCWB (HCW Biologics)|EV/EBITDA Multiple Aptevo Therapeutics, Inc. APVO|AIM: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation ADTX (Aditxt)|GRI: EV/EBITDA Multiple|XRTX - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vyome Holdings|Enterprise Value to EBITDA Ratio Revelation Biosciences Inc (REVB)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Indaptus (INDP)|Enterprise Value to EBITDA Ratio BiondVax Pharmaceuticals SCNI|CalciMedica - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Affimed NV AFMD|ALLK - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|HOOK (HOOKIPA Pharma Inc.) - Enterprise Value to Operating Income Before Depreciation|ITOS: EV/EBITDA Multiple|Company Value to EBITDA Ocean Biomedical Corp (OCEA)|TCBP (TC Biopharm) - EV/EBITDA Multiple|thirdharmonicbio.com (THRD) - Total Company Value to Operating Income Before Depreciation Ratio
